Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 3/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | SLC16A3 | O15427 | 7/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.47 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10872766 | 0.89 | FOLH1 (0.52) | FOLH1TSHRSLC16A3MRGPRX4 | |
| SCHEMBL1817886 | 0.86 | FOLH1 (0.66) | FOLH1KMT2ANR4A2MRGPRX4 | |
| SCHEMBL166927 | 0.86 | FOLH1 (0.66) | FOLH1TSHRALDH1A1ADRB2HTT | |
| SCHEMBL29975597 | 0.86 | FOLH1 (0.66) | FOLH1TSHRALDH1A1ADRB2HTT | |
| SCHEMBL30395109 | 0.86 | FOLH1 (0.66) | FOLH1KMT2ANR4A2MRGPRX4 | |
| SCHEMBL371526 | 0.86 | FOLH1 (0.70) | FOLH1KMT2ANR4A2MRGPRX4 | |
| SCHEMBL4861257 | 0.85 | TSHR (0.70) | FOLH1TSHRKMT2ANR4A2 | |
| SCHEMBL8702953 | 0.84 | FOLH1 (0.63) | FOLH1TSHRALDH1A1ADRB2HTT | |
| Hydrochloric Acid SCHEMBL7699238 | 0.84 | FOLH1 (0.63) | FOLH1TSHRALDH1A1ADRB2HTT | |
| SCHEMBL4394949 | 0.84 | FOLH1 (0.51) | FOLH1TSHRSLC16A3ALDH1A1ADRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2001087829-A1 | BISACYLGUANIDINE | MERCK PATENT GMBH (DE) | 2001-11-22 | — | — | WO | disclosed |